KCTD2: A Potential Drug Target and Biomarker for Various Diseases

Target Name: KCTD2

NCBI ID: G23510

KCTD2

KCTD2: A Potential Drug Target and Biomarker for Various Diseases

KCTD2 (KCTD2_HUMAN) is a protein that is expressed in various tissues of the human body, including the brain, heart, liver, and muscle. It is a member of the trigonide family, which is a family of cytoplasmic proteins that play important roles in various cellular processes.

KCTD2 is known for its unique structure and its ability to interact with various molecules, including drugs. Its unique shape allows it to form aggregates in aqueous environments, which can increase its surface area and enhance its ability to interact with other molecules.

Research has shown that KCTD2 can be a drug target, and several studies have investigated its potential as a potential drug target for various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

One of the reasons for the potential of KCTD2 as a drug target is its ability to interact with various signaling molecules, including G protein-coupled receptors (GPCRs), which are a family of transmembrane proteins that play important roles in cellular signaling. GPCRs are Involved in many important physiological processes in the body, including sensory perception, neurotransmission, and hormone signaling.

KCTD2 has been shown to interact with multiple GPCRs, including the GPCR known as SM-伪2 (also known as ARK4), which is involved in cell signaling and is a potential drug target for several diseases, including cancer.

In addition to its potential as a drug target, KCTD2 has also been shown to be a potential biomarker for several diseases. Its expression has been detected in various tissues of the body, including the brain, which suggests that it may be involved in the development and progression of certain neurological diseases.

KCTD2 has also been shown to be involved in the regulation of cellular processes that are important for maintaining the health and function of tissues. For example, it has been shown to be involved in the regulation of cell division and the maintenance of cellular stem cells, which are important for tissue repair and regeneration.

In conclusion, KCTD2 is a protein that has the potential to be a drug target for several diseases due to its unique structure and its ability to interact with various signaling molecules, including GPCRs. Its potential as a biomarker also makes it an important area of 鈥嬧?媟esearch for the development of new treatments for a variety of diseases.

Please note that the above article is not a real-world fact and is for educational purposes only.

Protein Name: Potassium Channel Tetramerization Domain Containing 2

The "KCTD2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KCTD2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets